Skip to Content
Merck
CN
  • A novel strategy for enzymatic synthesis of 4-hydroxyisoleucine: identification of an enzyme possessing HMKP (4-hydroxy-3-methyl-2-keto-pentanoate) aldolase activity.

A novel strategy for enzymatic synthesis of 4-hydroxyisoleucine: identification of an enzyme possessing HMKP (4-hydroxy-3-methyl-2-keto-pentanoate) aldolase activity.

FEMS microbiology letters (2007-06-15)
Sergey V Smirnov, Natalya N Samsonova, Anna E Novikova, Nikolay G Matrosov, Natalya Y Rushkevich, Tomohiro Kodera, Jun Ogawa, Hiroyuki Yamanaka, Sakayu Shimizu
ABSTRACT

A two-step enzymatic synthesis process of 4-hydroxyisoleucine is suggested. In the first step, the aldol condensation of acetaldehyde and alpha-ketobutyrate catalyzed by specific aldolase results in the formation of 4-hydroxy-3-methyl-2-keto-pentanoate (HMKP). In the second step, amination of HMKP by the branched-chain amino acid aminotransferase leads to synthesis of 4-hydroxyisoleucine. An enzyme possessing HMKP aldolase activity (asHPAL) was purified 2500-fold from a crude extract of Arthrobacter simplex strain AKU 626. Sequencing of the asHPAL structural gene showed that the purified enzyme belongs to the HpcH/HpaI aldolase family. The 4-hydroxyisoleucine was synthesized in vitro from acetaldehyde, alpha-ketobutyrate and l-glutamate using a coupled aldolase/branched-chain amino acid aminotransferase bienzymatic reaction.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2-Ketobutyric acid, 97%
Sigma-Aldrich
2-Oxobutyric acid, ≥95%, FG
Sigma-Aldrich
Sodium 2-oxobutyrate, powder